Kaplan-Meier plots of OS and LFS of 102 patients with CR vs CRi. (A-B) On day 30 post anti-CD19 CAR T-cell infusion, a total of 102 patients achieved morphologic CR with 60% (61 of 102) achieving CRi. There was a trend toward better OS (85.5% vs 59.7%; log-rank test P = .193; HR, 1.816; 95% CI, 0.739-4.462) and LFS (73.3% vs 57.4%; P = .123; HR, 0.54; 95% CI, 0.25-1.18) for patients with CR vs CRi.